A patient could either: Qualify for compassionate use, in which they demonstrated a health-based need for an experimental drug;3 or Go through a licensed peptide clinic operating within a regulatory gray area, in which the FDA did not universally enforce restrictions
Howells LM, Sale S, Sriramareddy SN, Irving GR, Jones DJ, Ottley CJ,
While necessary, this phase transforms toxins into "reactive intermediate metabolites" that are frequently more toxic and volatile than the original substance, generating massive amounts of free radicals
With experience in regenerative and longevity-focused therapies, your care is designed to align with current research, careful dosing strategies, and ongoing monitoring to ensure your plan supports both visible and cellular health goals
Caitlin is awesome and does such great work